Endocrine oncology

Contemporary Incidence and Survival of Lung Neuroendocrine Neoplasms

JAMA Netw OpenPublished Population-based retrospective cohort study

Authors' conclusion

The incidence of lung NENs has increased over 20 years, mostly associated with stage I disease. Prolonged OS was observed after lung NEN diagnosis. Patients with typical lung NET and stage I disease were more likely to die of causes other than lung cancer after 1 and 3 years, respectively. These data are important to direct efforts in care, research, and patient counseling.

Study context

Population
Adults with incident lung neuroendocrine neoplasms (NENs), Ontario, Canada, 2000–2020; median age 67 years, 56.3% female
Participants
4,479 adults
Outcome
Yearly incidence rates of lung NENs; OS; lung cancer-specific deaths (accounting for competing risk of death from other causes)
Methodological detailsData analyzed July to December 2024
  • Data analyzed July to December 2024

Main finding

As reported in the abstract

Incidence of lung NENs · 2000 to 2020
Typical neuroendocrine tumors (NET) incidence, per 100 000
0.51 to 1.09
Stage I incidence, per 100 000
0.68 to 1.18
5-year overall survival (OS)
50% (95% CI 49%-51%)
10-year OS
40% (95% CI 39%-41%)
Cumulative incidence of lung cancer-specific death at 5 years
41% (95% CI 40%-42%)
Cumulative incidence of lung cancer-specific death at 10 years
46% (95% CI 45%-47%)

Observational data: associations, not effects.

Further findings

Factors associated with OS and lung cancer-specific death

Advancing age, lower socioeconomic status, type of lung NEN and advancing stage independently associated with inferior OS
Advancing age, type of lung NEN and increasing stage independently associated with higher hazards of lung cancer-specific death
Deaths from other causes exceeded lung cancer-specific deaths from 2 years after diagnosis for typical NET and 3 years for stage I

Original publication

Contemporary Incidence and Survival of Lung Neuroendocrine Neoplasms. JAMA Netw Open. Published 1 October 2025. doi:10.1001/jamanetworkopen.2025.35125

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.